Stay updated with breaking news from Gudarz davar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ABX-002 was generally well-tolerated in Phase 1 program; topline data anticipated in fourth quarter 2023Preparations underway to initiate Phase 2 trial of ABX-002 in patients with major depressive disorder in the first half of 2024Company advancing novel, centrally-active S1P modulator, ABX-101, toward Phase 1 devel. ....
Autobahn Gets $32.7M for Depression Treatment - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea, Amgen and Abbott fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.